🔍 Rechercher dans les archives
Tesla intertwines FSD with in-house Insurance for attractive incentive
Every mile logged under FSD now carries a documented financial value—lower risk, lower cost—based on Tesla’s internal driving data rather than e...
Huge containers of liquid waste dumped by roadside
Containers dumped on the A35 leaked into a drainage channel, raising environmental concerns....
The Guardian view on social science research: embracing uncertainty | Editorial
Science rarely produces identical outcomes. Mistaking this for failure turns caution into an excuse for inaction A new set of studies out this month s...
Drought takes a heavy toll on bumblebees
Drought significantly reduces the reproductive success of bumblebee colonies, according to a new study conducted by a research team at the University ...
NanoTech Materials Raises $29.4 Million Series A to Scale High-Performance Infrastructure Materials
HOUSTON--(BUSINESS WIRE)--NanoTech Materials (NanoTech), an advanced material science company tackling the most urgent energy efficiency and fire resi...
Nucleai and Sirona Dx Partner to Deliver an Integrated Spatial Proteomics Solution for Pharma Drug Development
TEL AVIV, Israel--(BUSINESS WIRE)-- #AIpathology--Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specializ...
Amazon reveals smallest Fire Stick, huge TV that looks like a PAINTING & free upgrade for millions of telly fans
AMAZON is flogging its slimmest Fire Stick ever – and it starts at a thrifty £39.99 – and has dished out a free upgrade to existing gadget owners...
KDTV-001: a trivalent HPV vaccine with broad and durable antitumor immunity
While most human papillomavirus (HPV) infections are cleared by the host immune system, persistent infection with high-risk HPV genotypes, particularl...
Glyconex’s GNX-1021 cleared for clinic in Japan for GI cancers
Glyconex Inc. has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for the initiation of a first-in-human phase I tr...
Mabwell announces Chinese clinical trial clearance for SST-001
Mabwell (Shanghai) Bioscience Co. Ltd. has announced that SST-001 (18F-FD4), an α-synuclein-targeted PET tracer developed by Mabwell’s incubated co...
MASTL inhibitor shows robust antitumor efficacy
Microtubule-associated serine/threonine kinase-like protein (MASTL) is a key regulator of mitotic progression and cell-cycle control. Researchers from...
Early development of Olema and Aurigene’s OP-3136 for breast cancer
The discovery and development of new histone lysine acetyltransferase KAT6 inhibitors is a significant advancement in the management of breast cancer....
Biohaven reports details on discovery of BHV-2100
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including noci...
Science and standards: a comprehensive guide to radiological protection
New book provides an essential guide to the science, regulatory landscape and real world practice of radiological protection The post Science and stan...
DAERA Minister addresses Assembly on AFBI issues
DAERA Minister Andrew Muir has made an Oral Statement in the Northern Ireland Assembly on the Agri Food Bio Sciences Institute (AFBI) and associated g...
AgriSearch webinar examines Mycotoxin risk in forages and feeds
AgriSearch recently hosted a webinar titled “Mycotoxins in Forages and Feeds: Insights from the AgriSearch Study and International Research”, brin...
School league tables 2026: Here’s how Aberdeen, Aberdeenshire, Moray, Highlands and island secondary schools rank
How many leavers at your school achieved five or more Highers?...
Top 8 Lead Finder Tools for Accurate Prospecting in 2026
In 2026, accurate prospecting is no longer just about finding leads — it’s about finding the right leads with verified data you can actually use. ...
Galway’s Boston Scientific to advance therapies with €75m investment
The organisation has stated that the investment will strengthen Galway’s position as a global centre for cardiovascular innovation. Read more: Galwa...
Boston Scientific announces €75m R&D investment in Galway
The organisation has stated that the investment will strengthen Galway’s position as a global centre for cardiovascular innovation. Read more: Bosto...